Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cohort Study of Neoadjuvant Treatment Modalities for Esophageal Cancer

NCT04821843 is registered in ClinicalTrials.gov with Cancer Institute and Hospital, Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT04821843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04821843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cohort Study of Neoadjuvant Treatment Modalities for Esophageal Cancer
Lead sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase
Phase 3
Overall status
Recruiting
Start date
January 1, 2002
Completion date
December 31, 2030
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemoradiation, chemotherapy effect, esophageal cancer, esophagogastric juction cancer, immunotherapy, surgery, targeted therapy